DYAX CORP.

Patent Owner

Follow Compare Add to Portfolio 4Status Updates

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
 
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 60180
 
 
 
C07K PEPTIDES 5469
 
 
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 31128
 
 
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 26158
 
 
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 1876
 
 
 
C40B COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES, IN SILICO LIBRARIES 177
 
 
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 13107
 
 
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 793
 
 
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 6210
 
 
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 489

Top Patents (by citation)

Upgrade to the Premium Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2016/0194,397 FC RECEPTOR BINDING PROTEINSDec 31, 15Jul 07, 16[C07K]
2016/0102,150 PLASMA KALLIKREIN BINDING PROTEINSDec 15, 15Apr 14, 16[G01N, C07K]
2016/0040,157 MULTI-CHAIN EUKARYOTIC DISPLAY VECTORS AND USES THEREOFMay 21, 15Feb 11, 16[C12N]
2016/0017,055 ANTI-PLASMA KALLIKREIN ANTIBODIESMar 14, 14Jan 21, 16[C07K]
2015/0374,843 MULTIVALENT CONSTRUCTS FOR THERAPEUTIC AND DIAGNOSTIC APPLICATIONSApr 17, 15Dec 31, 15[A61K]
2015/0368,359 COMPOSITIONS AND METHODS FOR TREATING OPHTHALMIC DISORDERSJun 19, 15Dec 24, 15[A61K, C07K]
2015/0362,492 EVALUATION, ASSAYS AND TREATMENT OF PKAL-MEDIATED DISORDERSJan 17, 14Dec 17, 15[G01N, C07K]
2015/0362,493 EVALUATION AND TREATMENT OF BRADYKININ-MEDIATED DISORDERSJan 17, 14Dec 17, 15[G01N, C07K]
2015/0274,841 COMPOSITIONS AND METHODS FOR TREATMENT OF DIABETIC MACULAR EDEMAMar 26, 15Oct 01, 15[A61K, C07K]
2015/0218,218 PEPTIDES THAT SPECIFICALLY BIND HGF RECEPTOR (CMET) AND USES THEREOFFeb 19, 15Aug 06, 15[C07K]

View all Publication..

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9,386,938 Methods for collagen imagingSep 12, 11Jul 12, 16[A61B]
9,388,510 Libraries of genetic packages comprising novel HC CDR1, CDR2, and CDR3 and novel LC CDR1, CDR2, and CDR3 designsApr 24, 09Jul 12, 16[C40B, C07K]
9,382,535 Methods of constructing libraries of genetic packages that collectively display the members of a diverse family of peptides, polypeptides or proteinsFeb 28, 06Jul 05, 16[C12N, C07H, C40B, C12Q]
9,359,438 Human neonatal Fc receptor antibodies and methods of use thereofJun 01, 12Jun 07, 16[G01N, A61K, C07K]
9,266,964 Method of treating hereditary angioedema using plasma kallikrein binding antibodiesJun 20, 14Feb 23, 16[A61K, C07K]
9,260,520 Antibodies to FeRn and uses thereofJan 30, 14Feb 16, 16[A61K, G01N, C07K]
9,156,883 Binding molecules for human factor VIII and factor VIII-like proteinsAug 14, 13Oct 13, 15[C12N, G01N, C07K]
9,114,144 Kallikrein-inhibitor therapiesSep 08, 11Aug 25, 15[A61P, A61K]
9,116,149 Multi-chain eukaryotic display vectors and uses thereofJun 28, 11Aug 25, 15[C12N, C40B, C12P, G01N]
9,107,928 Compositions and methods for treating ophthalmic disordersJun 02, 10Aug 18, 15[A61P, A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2014/0199,324 EVALUATING PROTEIN EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCERABANMar 23, 12Jul 17, 14[G01N]
2013/0244,890 EVALUATING MMP EXPRESSION IN PATIENT STRATIFICATION AND OTHER THERAPEUTIC, DIAGNOSTIC AND PROGNOSTIC METHODS FOR CANCERABANApr 24, 12Sep 19, 13[C12Q, G01N]
2013/0189,944 TRACKING AND REPORTING INFORMATION CHARACTERIZING ATTACKS CAUSED BY A DISEASEABANJan 16, 13Jul 25, 13[H04W, G08B]
2013/0045,218 FC RECEPTOR BINDING PROTEINSABANAug 13, 12Feb 21, 13[A61P, A61K, G01N, C07K]
2012/0322,744 POLY-PEGYLATED PROTEASE INHIBITORSABANMay 03, 12Dec 20, 12[A61P, A61K, C07K]
8,183,008 Evaluating MMP expression in patient stratification and other therapeutic, diagnostic and prognostic methods for cancerExpiredDec 17, 08May 22, 12[C12Q]
2012/0027,686 HK1-BINDING PROTEINSABANJul 28, 11Feb 02, 12[C12N, C40B, A61P, G01N, A61K]
2011/0300,157 METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINSABANAug 01, 11Dec 08, 11[A61P, A61K, C07K]
2011/0262,396 COMBINATION TREATMENTS COMPRISING PROTEASE BINDING PROTEINS FOR INFLAMMATORY DISORDERSABANOct 22, 09Oct 27, 11[A61P, A61K]
2011/0262,446 USE OF IGF-II/IGF-IIE BINDING PROTEINS FOR THE TREATMENT AND PREVENTION OF SYSTEMIC SCLEROSIS ASSOCIATED PULMONARY FIBROSISABANOct 14, 09Oct 27, 11[A61P, A61K]
2011/0172,140 Poly-Pegylated Protease InhibitorsABANMay 26, 09Jul 14, 11[A61P, A61K, C07K]
2011/0165,145 IGF-II/IGF-IIE BINDING PROTEINSABANMay 08, 09Jul 07, 11[A61P, A61K, C07K]
2011/0152,193 INHIBITORS OF HUMAN PLASMIN DERIVED FROM THE KUNITZ DOMAINSABANFeb 25, 11Jun 23, 11[A61P, A61K]
2011/0135,573 METALLOPROTEINASE 9 AND METALLOPROTEINASE 2 BINDING PROTEINSABANSep 02, 10Jun 09, 11[C12N, A61P, G01N, A61K, C07K]
2011/0092,413 Albumin-Fused Kunitz Domain PeptidesABANNov 02, 10Apr 21, 11[C12N, C12P, A61P, A61K, C07K]
2011/0082,054 LIBRARIES OF GENETIC PACKAGES COMPRISING NOVEL HC CDR3 DESIGNSABANSep 14, 10Apr 07, 11[C40B]
7,919,462 Inhibitors of human plasmin derived from the Kunitz domainsExpiredOct 30, 07Apr 05, 11[A61K]
2011/0059,105 TIE COMPLEX BINDING PROTEINSABANJun 28, 10Mar 10, 11[A61P, G01N, A61K, C07K]
7,893,007 Directed evolution of novel binding proteinsExpiredOct 22, 08Feb 22, 11[C40B]
2010/0291,001 METALLOPROTEINASE-BINDING PROTEINSABANDec 19, 08Nov 18, 10[C12N, C07H, A61P, C12P, G01N, A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Premium Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.